DaVita

News

Reuters - 3 weeks ago

FMC specifies 2024 guidance as it tops Q3 core profit forecast

UPDATE 2-FMC slightly raises 2024 guidance as it tops Q3 core profit forecast Adds CEO quotes in paragraphs 3, 9, shares in paragraph 6, peer performance in paragraph 7 By Bartosz Dabrowski and Patricia Weiss Nov 5 (Reuters) - Dialysis specialist Fresenius Medical Care FMEG.DE slightly raised the lower end of its 2024 operating profit forecast range on Tuesady after posting quarterly earnings above expectations, helped by cost savings and as its U.S.

Reuters - 4 weeks ago

U.S. STOCKS Zimmer Biomet, Shake Shack, Microsoft

BUZZ-U.S. STOCKS ON THE MOVE-Zimmer Biomet, Shake Shack, Microsoft Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock indexes advanced on Wednesday, with the tech-heavy Nasdaq rising to a record high, as investors assessed corporate earnings as well as crucial data showing the economy maintained a steady pace of growth in the third quarter.

Reuters - 4 weeks ago

DaVita Inc reports results for the quarter ended in January 1 - Earnings Summary

DaVita Inc reports results for the quarter ended in January 1 - Earnings Summary DaVita Inc DVA.N reported quarterly adjusted earnings of $2.50 per share for the quarter ended January 1, lower than the same quarter last year, when the company reported EPS of $2.62. The mean expectation of seven analysts for the quarter was for earnings of $2.73 per share.

Reuters - 4 weeks ago

Dialysis firm DaVita misses third-quarter profit estimates on higher costs

UPDATE 3-Dialysis firm DaVita misses third-quarter profit estimates on higher costs Updates shares, adds details from conference call in paragraphs 3-7 By Sneha S K Oct 29 (Reuters) - Dialysis firm DaVita DVA.N reported third -quarter profit below Wall Street estimates on Tuesday due to increased labor costs and other expenses tied to patient care, sending its shares down 5 .3 % after the bell.

Reuters - 4 weeks ago

DaVita misses third-quarter profit estimates on higher costs

DaVita misses third-quarter profit estimates on higher costs Oct 29 (Reuters) - DaVita DVA.N reported third-quarter profit that missed Wall Street estimates on Tuesday, hurt by high patient care costs . On an adjusted basis, it reported third-quarter profit of $2.59 per share, below analysts' estimate of $2.73 per share. Reporting by Sneha S K; Edi

Reuters - 4 weeks ago

Election-agitated Treasuries meet megacap earnings

MORNING BID AMERICAS-Election-agitated Treasuries meet megacap earnings A look at the day ahead in U.S. and global markets from Mike Dolan Even as public borrowing estimates were shaved on Monday, U.S. Treasury yields continue to probe three-month highs as markets lean toward a win for Donald Trump in next week's election and a possible clean sweep in Congress for his Republican party.

Reuters - 4 weeks ago

What to Watch in the Day Ahead - Tuesday, October 29

What to Watch in the Day Ahead - Tuesday, October 29 The Day Ahead is an email and PDF publication that includes the day's major stories and events, analyses and other features. To receive The Day Ahead, Eikon users can register at DAY/US . Thomson One users can register at RT/DAY/US. All times in ET/GMT Alphabet will report results for its third quarter.

Reuters - 2 months ago

DaVita Appoints David Maughan As Chief Operating Officer

BRIEF-DaVita Appoints David Maughan As Chief Operating Officer Sept 13 (Reuters) - DaVita Inc DVA.N : DAVITA APPOINTS DAVID MAUGHAN NEW CHIEF OPERATING OFFICER, MIKE STAFFIERI STEPS INTO EMERITUS ROLE Source text for Eikon: ID:nPn89slw5a Further company coverage: DVA.N

Reuters - 2 months ago

S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT

BUZZ - S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT S&P 500 .SPX Top Performers Percent Change Warner Bros Discovery Inc WBD.OQ +7.6% Kroger Co KR.N +5.6% Axon Enterprise Inc AXON.OQ +4.3% DaVita Inc DVA.N +4.0% Dollar General Corp DG.N +3.9% Bottom Performers Percent Change Moderna Inc MRNA.OQ -17.1% Micron Technology Inc MU.OQ

Reuters - 2 months ago

U.S. Cintas, Sprouts Farmers Market, Voya Financial

U.S. RESEARCH ROUNDUP-Cintas, Sprouts Farmers Market, Voya Financial Sept 12 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Cintas Corp, Sprouts Farmers market and Voya Financial, on Thursday. HIGHLIGHTS * Ally Financial Inc ALLY.N : RBC cuts target price to $40 from $49 * Cintas Corp CTAS.O : CFRA adjusts target price to $170 from $645 to reflect 4-for-1 stock split * Gilead GILD.O : Raymond James raises target pri

Reuters - 3 months ago

U.S. STOCKS Primerica, Affirm Holdings, 3D Systems

BUZZ-U.S. STOCKS ON THE MOVE-Primerica, Affirm Holdings, 3D Systems Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The Nasdaq and the S&P 500 inched up in choppy trading on Friday ahead of a long weekend, after signs of moderating price pressures, strengthened bets for an interest-rate cut at the U.S.

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.